Abstract
Metastatic lymph-node ratio, which is defined as the ratio of positive nodes out of all of the retrieved nodes) has been demonstrated to be a prognostic factor in colon cancer, whereas its role in extraperitoneal rectal cancer after chemoradiation is debated. The aim of our study was to investigate the prognostic impact of lymph-node ratio in stage III rectal cancer after neoadjuvant treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
